AIIMS director Randeep Guleria said on Sunday that India will use only Oxford-AstraZeneca vaccines in the first phase of COVID-19 Bharat Biotech’s vaccination and Covaxin are just a backup in case the more infectious UK variant of the virus gets out of control. Both vaccines have received approval for emergency …
Read More »
One day after Samajwadi Party chief Akhilesh Yadav questioned India’s Covid-19 vaccines and said he would not take “the BJP vaccine,” Congressional leaders Jairam Ramesh, Shashi Tharoor also doubted approval. awarded to the Bharat Biotech vaccine while in its third phase of testing. . Criticizing their doubts, Union Minister Hardeep …
Read More »
Congressional Senior Leader Shashi Tharoor said on Sunday that emergency approval for the Covid-19 – Covaxin vaccine is premature and could be dangerous as it is still in phase 3 testing. He urged the Union Health Minister Dr. Harsh Vardhan to wait until full trials of the vaccine are completed. …
Read More »
After the Controller General of Drugs of India (DCGI) gave the green signal on Sunday to two candidate vaccines for restricted and emergency use, Union Minister Rajnath Singh praised Prime Minister Narendra Modi’s vision for Aatmanirbhar Bharat, who said that he has greatly helped India to come. with indigenous solutions …
Read More »
After the The Comptroller General of Drugs of India (DCGI) approved on Sunday the emergency use of Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin for Covid-19 immunization in India, Prime Minister Narendra Modi tweeted that all Indians are proud that both injections are “made in India.” Stating that the DGCI approval …
Read More »
The Comptroller General of Drugs of India (DCGI) on Sunday gave emergency use approval to COVISHIELD, the coronavirus vaccine developed by Bharat Biotech, and the other by AstraZeneca and the University of Oxford. Shortly after the vaccine announcement, Serum Institute of India Executive Director Adar Poonawalla wished the people of …
Read More »
For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »
The head of India’s drug regulator will deliver a press conference on Sunday, a day after his experts recommended allowing the emergency use in the country of the Oxford-AstraZeneca and Bharat Biotech vaccines against the coronavirus disease ( Covid-19), according to reports. . The Comptroller General of Drugs of India …
Read More »
Covaxin, the indigenous Covid-19 vaccine, developed by Bharat Biotech in collaboration with the Indian Council for Medical Research and the National Institute of Virology, became the second vaccine in India to take a further step towards final approval for emergency use. . The Central Drug Control Organization (CDSCO) subject matter …
Read More »
An expert panel from India’s top drug regulator on Saturday recommended restricted emergency approval for Covaxin, Bharat Biotech’s Covid-19 candidate vaccine currently being tested in the country. The panel of experts now recommended a restricted authorization for two candidate vaccines in as many days; on Friday, it recommended similar approval …
Read More »